Status: current, Primitive. Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3645968012 | Genetically modified T-cell (substance) | en | Fully specified name | Active | Initial character case insensitive | SNOMED CT core |
| 3645969016 | Genetically modified T-lymphocyte | en | Synonym | Active | Initial character case insensitive | SNOMED CT core |
| 3645970015 | Genetically modified T-cell | en | Synonym | Active | Initial character case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Genetically modified T-cell | Is a | Immunologic substance | true | Inferred relationship | Some | ||
| Genetically modified T-cell | Is a | Drug or medicament | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Brexucabtagene autoleucel | Is a | True | Genetically modified T-cell | Inferred relationship | Some | |
| Lisocabtagene maraleucel | Is a | True | Genetically modified T-cell | Inferred relationship | Some | |
| Idecabtagene vicleucel | Is a | True | Genetically modified T-cell | Inferred relationship | Some | |
| Tisagenlecleucel | Is a | True | Genetically modified T-cell | Inferred relationship | Some | |
| Genetically modified T-cell-containing product | Has active ingredient | True | Genetically modified T-cell | Inferred relationship | Some | 1 |
| Axicabtagene ciloleucel | Is a | True | Genetically modified T-cell | Inferred relationship | Some |
Reference Sets
Substance foundation reference set
FHIR